Dual Pathway Inhibition in Patients with Atherosclerosis with or without Heart Failure: Insights from the XATOA Registry by Pishoy Gouda, MB, BCh, BAO, MSc, Justin A. Ezekowitz, MD, MSc, Alain Gay, MD, Kai Vogtländer, MSc, Victor Aboyans, MD, PhD, Sebastian Debus, MD, Keith Fox, MB, ChB, Uwe Zeymer, MD, Robert Welsh, MD

Get full text